Lytix Biopharma to present at ABG Sundal Collier Life Science Summit and Redeye Growth Day in Stockholm
Oslo, 25 May 2023. Lytix Biopharma – Lytix Biopharma AS (“Lytix”) (Euronext Growth Oslo: LYTIX), a Norwegian immuno-oncology company – is pleased to announce that Dr Øystein Rekdal, CEO in Lytix Biopharma, will be presenting the company at two events in Stockholm next week.· The ABG Sundal Collier Life Science Summit, Wednesday 31 May at 11:30 CET · Redeye Growth Day 2023, Thursday 1 June at 12:55 CET A prerecorded Lytix presentation for Redeye Growth Day is available at https://www.redeye.se/video/company-prerecorded-presentation/911051/lytix-biopharma